» Articles » PMID: 3720691

Lysophosphatidylcholine Increases Airway and Capillary Permeability in the Isolated Perfused Rat Lung

Overview
Journal Exp Lung Res
Publisher Informa Healthcare
Specialty Pulmonary Medicine
Date 1986 Jan 1
PMID 3720691
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of lysophosphatidylcholine (lysoPC) on airway and capillary permeability in the isolated perfused rat lung were investigated. We determined the influence of lysoPC on the passage of different-sized (326-722 dalton) polyethylene glycols (PEGs), both from the airways to the pulmonary circulation and from the pulmonary circulation into the lung. We found that 1 mM lysoPC increased the overall passage of PEGs from the airways to the pulmonary circulation, and that 80 microM lysoPC increased the overall passage from the circulation into the lung. In both cases, the passage of the larger (502-722 dalton) PEGs increased more than the passage of the smaller (326-458 dalton) PEGs. We also found that the presence of lysoPC in the circulation increased the pulmonary arterial pressure, whereas deposition of lysoPC in the trachea did not. The pressure increase was blocked by indomethacine, BW755C, and quinacrine, inhibitors of arachidonic acid metabolism. These findings suggest that higher concentrations of lysoPC increase the airway permeability to larger molecules, and that lower concentrations of lysoPC increase the capillary permeability. The increase in capillary permeability may be due to a rise in capillary pressure mediated by arachidonic acid metabolites. The possibility that formation and accumulation of lysoPC is of importance for mediating inflammatory reactions in the lung is inferred.

Citing Articles

Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia.

Cui L, Zheng D, Lee Y, Chan T, Kumar Y, Ho W Sci Rep. 2016; 6:26076.

PMID: 27188343 PMC: 4870563. DOI: 10.1038/srep26076.


Stimulated bronchial epithelial cells release bioactive lysophosphatidylcholine 16:0, 18:0, and 18:1.

Zhuge Y, Yuan Y, van Breemen R, Degrand M, Holian O, Yoder M Allergy Asthma Immunol Res. 2014; 6(1):66-74.

PMID: 24404396 PMC: 3881404. DOI: 10.4168/aair.2014.6.1.66.


Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects.

Yoder M, Zhuge Y, Yuan Y, Holian O, Kuo S, van Breemen R Allergy Asthma Immunol Res. 2014; 6(1):61-5.

PMID: 24404395 PMC: 3881403. DOI: 10.4168/aair.2014.6.1.61.


Basis of rise in intracellular sodium in airway hyperresponsiveness and asthma.

Agrawal A, Agrawal K, Ram A, Sondhi A, Chhabra S, Gangal S Lung. 2006; 183(6):375-87.

PMID: 16465598 DOI: 10.1007/s00408-005-2549-0.


Novel lysophospholipase A secreted by Legionella pneumophila.

Flieger A, Gong S, Faigle M, Stevanovic S, Cianciotto N, Neumeister B J Bacteriol. 2001; 183(6):2121-4.

PMID: 11222614 PMC: 95111. DOI: 10.1128/JB.183.6.2121-2124.2001.